BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dunn TB, Noreen H, Gillingham K, Maurer D, Ozturk OG, Pruett TL, Bray RA, Gebel HM, Matas AJ. Revisiting traditional risk factors for rejection and graft loss after kidney transplantation. Am J Transplant. 2011;11:2132-2143. [PMID: 21812918 DOI: 10.1111/j.1600-6143.2011.03640.x] [Cited by in Crossref: 141] [Cited by in F6Publishing: 122] [Article Influence: 12.8] [Reference Citation Analysis]
Number Citing Articles
1 Sethi S, Najjar R, Peng A, Mirocha J, Vo A, Bunnapradist S, Jordan SC, Huang E. Allocation of the Highest Quality Kidneys and Transplant Outcomes Under the New Kidney Allocation System. American Journal of Kidney Diseases 2019;73:605-14. [DOI: 10.1053/j.ajkd.2018.12.036] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
2 Wall A, Bueno E, Pomahac B, Treister N. Intraoral features and considerations in face transplantation. Oral Dis 2016;22:93-103. [DOI: 10.1111/odi.12301] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
3 Pratschke J, Dragun D, Hauser IA, Horn S, Mueller TF, Schemmer P, Thaiss F. Immunological risk assessment: The key to individualized immunosuppression after kidney transplantation. Transplantation Reviews 2016;30:77-84. [DOI: 10.1016/j.trre.2016.02.002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
4 Maxfield SJ, Taylor CJ, Kosmoliaptsis V, Broecker V, Watson CJE, Bradley JA, Peacock S. Transfer of HLA-Specific Allosensitization From a Highly Sensitized Deceased Organ Donor to the Recipients of Each Kidney: Donor Derived De Novo HLA-Allosensitization. American Journal of Transplantation 2015;15:2501-6. [DOI: 10.1111/ajt.13300] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
5 von Moos S, Cippà PE, van Breemen R, Mueller TF. HLA antibodies are associated with deterioration of kidney allograft function irrespective of donor specificity. Hum Immunol 2021;82:19-24. [PMID: 33162184 DOI: 10.1016/j.humimm.2020.10.010] [Reference Citation Analysis]
6 Grow DA, McCarrey JR, Navara CS. Advantages of nonhuman primates as preclinical models for evaluating stem cell-based therapies for Parkinson's disease. Stem Cell Res 2016;17:352-66. [PMID: 27622596 DOI: 10.1016/j.scr.2016.08.013] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 6.2] [Reference Citation Analysis]
7 Kamburova EG, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Sanders JSF, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens M, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG. Differential effects of donor-specific HLA antibodies in living versus deceased donor transplant. Am J Transplant 2018;18:2274-84. [PMID: 29464832 DOI: 10.1111/ajt.14709] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 7.0] [Reference Citation Analysis]
8 Mannon RB, Askar M, Jackson AM, Newell K, Mengel M. Meeting report of the STAR-Sensitization in Transplantation Assessment of Risk: Naïve Abdominal Transplant Organ subgroup focus on kidney transplantation. Am J Transplant 2018;18:2120-34. [PMID: 29943908 DOI: 10.1111/ajt.14977] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
9 Spasovski G, Masin-Spasovska J. How to improve the survival of the kidney transplant - is it only the pharmaceutical management? Expert Opin Pharmacother 2014;15:905-8. [PMID: 24617949 DOI: 10.1517/14656566.2014.896900] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Burkhalter F, Schaub S, Bucher C, Gürke L, Bachmann A, Hopfer H, Dickenmann M, Steiger J, Binet I. A Comparison of Two Types of Rabbit Antithymocyte Globulin Induction Therapy in Immunological High-Risk Kidney Recipients: A Prospective Randomized Control Study. PLoS One 2016;11:e0165233. [PMID: 27855166 DOI: 10.1371/journal.pone.0165233] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
11 O'Leary JG, Demetris AJ, Friedman LS, Gebel HM, Halloran PF, Kirk AD, Knechtle SJ, McDiarmid SV, Shaked A, Terasaki PI, Tinckam KJ, Tomlanovich SJ, Wood KJ, Woodle ES, Zachary AA, Klintmalm GB. The role of donor-specific HLA alloantibodies in liver transplantation. Am J Transplant 2014;14:779-87. [PMID: 24580828 DOI: 10.1111/ajt.12667] [Cited by in Crossref: 133] [Cited by in F6Publishing: 117] [Article Influence: 16.6] [Reference Citation Analysis]
12 Lebranchu Y, Baan C, Biancone L, Legendre C, Morales JM, Naesens M, Thomusch O, Friend P. Pretransplant identification of acute rejection risk following kidney transplantation. Transpl Int 2014;27:129-38. [DOI: 10.1111/tri.12205] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 5.1] [Reference Citation Analysis]
13 Stites E, Le Quintrec M, Thurman JM. The Complement System and Antibody-Mediated Transplant Rejection. J Immunol 2015;195:5525-31. [PMID: 26637661 DOI: 10.4049/jimmunol.1501686] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 5.5] [Reference Citation Analysis]
14 Wu K, Schmidt D, López Del Moral C, Osmanodja B, Lachmann N, Zhang Q, Halleck F, Choi M, Bachmann F, Ronicke S, Duettmann W, Naik MG, Schrezenmeier E, Rudolph B, Budde K. Poor Long-Term Renal Allograft Survival in Patients with Chronic Antibody-Mediated Rejection, Irrespective of Treatment-A Single Center Retrospective Study. J Clin Med 2021;11:199. [PMID: 35011939 DOI: 10.3390/jcm11010199] [Reference Citation Analysis]
15 Tait BD, Süsal C, Gebel HM, Nickerson PW, Zachary AA, Claas FH, Reed EF, Bray RA, Campbell P, Chapman JR. Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation. Transplantation. 2013;95:19-47. [PMID: 23238534 DOI: 10.1097/tp.0b013e31827a19cc] [Cited by in Crossref: 525] [Cited by in F6Publishing: 144] [Article Influence: 58.3] [Reference Citation Analysis]
16 Goumard A, Sautenet B, Bailly E, Miquelestorena-Standley E, Proust B, Longuet H, Binet L, Baron C, Halimi JM, Büchler M, Gatault P. Increased risk of rejection after basiliximab induction in sensitized kidney transplant recipients without pre-existing donor-specific antibodies - a retrospective study. Transpl Int 2019;32:820-30. [PMID: 30903722 DOI: 10.1111/tri.13428] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
17 Faddoul G, Nadkarni GN, Bridges ND, Goebel J, Hricik DE, Formica R, Menon MC, Morrison Y, Murphy B, Newell K, Nickerson P, Poggio ED, Rush D, Heeger PS; CTOT-17 consortium. Analysis of Biomarkers Within the Initial 2 Years Posttransplant and 5-Year Kidney Transplant Outcomes: Results From Clinical Trials in Organ Transplantation-17. Transplantation. 2018;102:673-680. [PMID: 29189482 DOI: 10.1097/tp.0000000000002026] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 5.3] [Reference Citation Analysis]
18 Fujiyama N, Satoh S, Saito M, Numakura K, Inoue T, Yamamoto R, Saito T, Kanda S, Narita S, Mitobe Y, Habuchi T. Impact of persistent preformed and de novo donor-specific antibodies detected at 1 year after kidney transplantation on long-term graft survival in Japan: a retrospective study. Clin Exp Nephrol 2019;23:1398-406. [PMID: 31493185 DOI: 10.1007/s10157-019-01780-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Malheiro J, Tafulo S, Dias L, Martins S, Fonseca I, Beirão I, Castro-Henriques A, Cabrita A. Determining donor-specific antibody C1q-binding ability improves the prediction of antibody-mediated rejection in human leucocyte antigen-incompatible kidney transplantation. Transpl Int 2017;30:347-59. [PMID: 27717025 DOI: 10.1111/tri.12873] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
20 Turolo S, Edefonti A, Ghio L, Testa S, Morello W, Montini G. CYP and SXR gene polymorphisms influence in opposite ways acute rejection rate in pediatric patients with renal transplant. BMC Pediatr 2020;20:246. [PMID: 32450827 DOI: 10.1186/s12887-020-02152-3] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Varnell CD Jr, Rich KL, Zhang B, Carle AC, Pai ALH, Modi AC, Hooper DK. Predicting acute rejection in children, adolescents, and young adults with a kidney transplant by assessing barriers to taking medication. Pediatr Nephrol 2021;36:2453-61. [PMID: 33501558 DOI: 10.1007/s00467-021-04946-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Passamonti SM, Cannavò A, Espadas de Arias A, Innocente A, Ramondetta M, Regalia A, Messa P, Ferraresso M, Cardillo M. Pretransplant Single Antigen Bead-Detected HLA Antibodies in Kidney Transplant Long-term Outcome: A Single-Center Cohort Experience. Transplant Proc 2019;51:707-14. [PMID: 30979454 DOI: 10.1016/j.transproceed.2019.01.063] [Reference Citation Analysis]
23 Weber S, Dienemann T, Jacobi J, Eckardt KU, Weidemann A. Delayed graft function is associated with an increased rate of renal allograft rejection: A retrospective single center analysis. PLoS One 2018;13:e0199445. [PMID: 29928026 DOI: 10.1371/journal.pone.0199445] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
24 Huber L, Lachmann N, Dürr M, Matz M, Liefeldt L, Neumayer H, Schönemann C, Budde K. Identification and Therapeutic Management of Highly Sensitized Patients Undergoing Renal Transplantation: . Drugs 2012;72:1335-54. [DOI: 10.2165/11631110-000000000-00000] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
25 Chan GS, Kwok J, Lam MF, Chan TM, Chan KW. Renal allograft tissue: its new role in patient management. Histopathology 2012;60:1160-2. [PMID: 22439775 DOI: 10.1111/j.1365-2559.2012.04215.x] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
26 Thammanichanond D, Sukhumvat S, Tammakorn C, Siriyotha S, Kantachuvesiri S. Comparison Between Phenotypic Bead Assay and Single Antigen Bead Assay for Determining Specificity of HLA Antibodies in Kidney Transplant Waiting List. Transplant Proc 2020;52:1675-9. [PMID: 32448666 DOI: 10.1016/j.transproceed.2020.01.153] [Reference Citation Analysis]
27 Konvalinka A, Tinckam K. Utility of HLA Antibody Testing in Kidney Transplantation. J Am Soc Nephrol. 2015;26:1489-1502. [PMID: 25804279 DOI: 10.1681/asn.2014080837] [Cited by in Crossref: 103] [Cited by in F6Publishing: 32] [Article Influence: 14.7] [Reference Citation Analysis]
28 Chopra B, Sureshkumar K. Human Leukocyte Antigen Mismatch and Steroid Maintenance in Kidney Transplantation. Transplantation Proceedings 2015;47:2852-4. [DOI: 10.1016/j.transproceed.2015.10.028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
29 Coelho V, Saitovitch D, Kalil J, Silva HM. Rethinking the multiple roles of B cells in organ transplantation. Current Opinion in Organ Transplantation 2013;18:13-21. [DOI: 10.1097/mot.0b013e32835c8043] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 1.9] [Reference Citation Analysis]
30 Pereira M, Guerra J, Neves M, Gonçalves J, Santana A, Nascimento C, da Costa AG. Predictive Factors of Acute Rejection in Low Immunologic Risk Kidney Transplant Recipients Receiving Basiliximab. Transplant Proc 2016;48:2280-3. [PMID: 27742279 DOI: 10.1016/j.transproceed.2016.06.022] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
31 Srinivas TR, Oppenheimer F. Identifying endpoints to predict the influence of immunosuppression on long-term kidney graft survival. Clin Transplant 2015;29:644-53. [DOI: 10.1111/ctr.12554] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
32 Lee J, Lee JJ, Kim BS, Lee JG, Huh KH, Park Y, Kim YS. A 12-month single arm pilot study to evaluate the efficacy and safety of sirolimus in combination with tacrolimus in kidney transplant recipients at high immunologic risk. J Korean Med Sci 2015;30:682-7. [PMID: 26028917 DOI: 10.3346/jkms.2015.30.6.682] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
33 Ponsirenas RVG, Cazarote HB, Araújo SA, Wanderley DC, Shimakura S, Valdameri JS, Contieri FLC, von Glehn CCQC, Susin MF, Sotomaior VS. Anti-HLA Donor-Specific IgG Subclasses and C1q-binding Evolution in Posttransplant Monitoring. Transplant Direct 2018;4:e385. [PMID: 30234154 DOI: 10.1097/TXD.0000000000000823] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
34 Townamchai N, Eiam-Ong S. Biomarkers in kidney transplantation: From bench to bedside. World J Nephrol 2015; 4(5): 487-491 [PMID: 26558185 DOI: 10.5527/wjn.v4.i5.487] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
35 Geneugelijk K, Niemann M, de Hoop T, Spierings E. Completion of HLA protein sequences by automated homology-based nearest-neighbor extrapolation of HLA database sequences. Hum Immunol 2016;77:1030-6. [PMID: 27060031 DOI: 10.1016/j.humimm.2016.04.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
36 Visentin J, Guidicelli G, Moreau JF, Lee JH, Taupin JL. Deciphering allogeneic antibody response against native and denatured HLA epitopes in organ transplantation. Eur J Immunol 2015;45:2111-21. [PMID: 25824860 DOI: 10.1002/eji.201445340] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
37 Franzin R, Stasi A, Fiorentino M, Stallone G, Cantaluppi V, Gesualdo L, Castellano G. Inflammaging and Complement System: A Link Between Acute Kidney Injury and Chronic Graft Damage. Front Immunol 2020;11:734. [PMID: 32457738 DOI: 10.3389/fimmu.2020.00734] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 10.0] [Reference Citation Analysis]
38 Blazquez-navarro A, Bauer C, Wittenbrink N, Wolk K, Sabat R, Dang-heine C, Neumann S, Roch T, Wehler P, Blazquez-navarro R, Olek S, Thomusch O, Seitz H, Reinke P, Hugo C, Sawitzki B, Babel N, Or-guil M. Early prediction of renal graft function: Analysis of a multi-center, multi-level data set. Current Research in Translational Medicine 2022;70:103334. [DOI: 10.1016/j.retram.2022.103334] [Reference Citation Analysis]
39 Comoli P, Cioni M, Tagliamacco A, Quartuccio G, Innocente A, Fontana I, Trivelli A, Magnasco A, Nocco A, Klersy C, Rubert L, Ramondetta M, Zecca M, Garibotto G, Ghiggeri GM, Cardillo M, Nocera A, Ginevri F. Acquisition of C3d-Binding Activity by De Novo Donor-Specific HLA Antibodies Correlates With Graft Loss in Nonsensitized Pediatric Kidney Recipients. Am J Transplant 2016;16:2106-16. [PMID: 26725780 DOI: 10.1111/ajt.13700] [Cited by in Crossref: 66] [Cited by in F6Publishing: 58] [Article Influence: 11.0] [Reference Citation Analysis]
40 Liefeldt L, Brakemeier S, Glander P, Waiser J, Lachmann N, Schönemann C, Zukunft B, Illigens P, Schmidt D, Wu K, Rudolph B, Neumayer H, Budde K. Donor-Specific HLA Antibodies in a Cohort Comparing Everolimus With Cyclosporine After Kidney Transplantation: DSA Risk and Immunosuppression after KTX. American Journal of Transplantation 2012;12:1192-8. [DOI: 10.1111/j.1600-6143.2011.03961.x] [Cited by in Crossref: 182] [Cited by in F6Publishing: 159] [Article Influence: 18.2] [Reference Citation Analysis]
41 Fu Q, Zhang H, Nie W, Deng R, Li J, Xiong Y, Dai Y, Liu L, Yuan X, He X, Wang C. Risk Factors for Acute Rejection After Deceased Donor Kidney Transplantation in China. Transplant Proc 2018;50:2465-8. [PMID: 30316380 DOI: 10.1016/j.transproceed.2018.03.063] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
42 Fischer M, Leyking S, Schäfer M, Elsäßer J, Janssen M, Mihm J, van Bentum K, Fliser D, Sester M, Sester U. Donor-specific alloreactive T cells can be quantified from whole blood, and may predict cellular rejection after renal transplantation. Eur J Immunol 2017;47:1220-31. [PMID: 28426152 DOI: 10.1002/eji.201646826] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
43 Wu K, Schmidt D, López del Moral C, Osmanodja B, Lachmann N, Halleck F, Choi M, Bachmann F, Ronicke S, Duettmann W, Naik M, Schrezenmeier E, Rudolph B, Budde K. Poor Outcomes in Patients With Transplant Glomerulopathy Independent of Banff Categorization or Therapeutic Interventions. Front Med 2022;9:889648. [DOI: 10.3389/fmed.2022.889648] [Reference Citation Analysis]
44 Marks WH, Mamode N, Montgomery RA, Stegall MD, Ratner LE, Cornell LD, Rowshani AT, Colvin RB, Dain B, Boice JA, Glotz D; C10-001 Study Group. Safety and efficacy of eculizumab in the prevention of antibody-mediated rejection in living-donor kidney transplant recipients requiring desensitization therapy: A randomized trial. Am J Transplant 2019;19:2876-88. [PMID: 30887675 DOI: 10.1111/ajt.15364] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 11.3] [Reference Citation Analysis]
45 Lan JH, Kadatz M, Chang DT, Gill J, Gebel HM, Gill JS. Pretransplant Calculated Panel Reactive Antibody in the Absence of Donor-Specific Antibody and Kidney Allograft Survival. Clin J Am Soc Nephrol 2021;16:275-83. [PMID: 33495290 DOI: 10.2215/CJN.13640820] [Reference Citation Analysis]
46 Glotz D, Russ G, Rostaing L, Legendre C, Tufveson G, Chadban S, Grinyó J, Mamode N, Rigotti P, Couzi L, Büchler M, Sandrini S, Dain B, Garfield M, Ogawa M, Richard T, Marks WH; C10-002 Study Group. Safety and efficacy of eculizumab for the prevention of antibody-mediated rejection after deceased-donor kidney transplantation in patients with preformed donor-specific antibodies. Am J Transplant 2019;19:2865-75. [PMID: 31012541 DOI: 10.1111/ajt.15397] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 8.7] [Reference Citation Analysis]
47 Visentin J, Guidicelli G, Couzi L, Merville P, Lee JH, Di Primo C, Taupin JL. Deciphering IgM interference in IgG anti-HLA antibody detection with flow beads assays. Hum Immunol 2016;77:1048-54. [PMID: 26902993 DOI: 10.1016/j.humimm.2016.02.008] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
48 Hickey MJ, Valenzuela NM, Reed EF. Alloantibody Generation and Effector Function Following Sensitization to Human Leukocyte Antigen. Front Immunol 2016;7:30. [PMID: 26870045 DOI: 10.3389/fimmu.2016.00030] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 4.2] [Reference Citation Analysis]
49 Viglietti D, Lefaucheur C, Glotz D. Evidence for an important role of both complement-binding and noncomplement-binding donor-specific antibodies in renal transplantation. Curr Opin Organ Transplant 2016;21:433-40. [PMID: 27348472 DOI: 10.1097/MOT.0000000000000324] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
50 Nasrallah M, Elalfy M, Fakhry S, Rostaing L, Amer I, Elmeseery Y, Mohammed I, El-gamal A, Malvezzi P. Impact of Adopting Routine Luminex-Based Pretransplant Assessment of HLA Antibodies on Clinical Practice and Outcomes in Kidney Transplantation. Transplantation Proceedings 2019;51:2241-4. [DOI: 10.1016/j.transproceed.2019.01.147] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
51 Lucisano G, Thiruvengadam S, Hassan S, Gueret-Wardle A, Brookes P, Santos-Nunez E, Willicombe M. Donor-specific antibodies detected by single antigen beads alone can help risk stratify patients undergoing retransplantation across a repeat HLA mismatch. Am J Transplant 2020;20:441-50. [PMID: 31529621 DOI: 10.1111/ajt.15595] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
52 Malheiro J, Tafulo S, Dias L, Martins S, Fonseca I, Beirão I, Castro-Henriques A, Cabrita A. Impact on mid-term kidney graft outcomes of pretransplant anti-HLA antibodies detected by solid-phase assays: Do donor-specific antibodies tell the whole story? Hum Immunol 2017;78:526-33. [PMID: 28732720 DOI: 10.1016/j.humimm.2017.07.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
53 Adebiyi OO, Gralla J, Klem P, Freed B, Davis S, Wiseman AC, Cooper JE. Clinical Significance of Pretransplant Donor-Specific Antibodies in the Setting of Negative Cell-Based Flow Cytometry Crossmatching in Kidney Transplant Recipients. Am J Transplant 2016;16:3458-67. [DOI: 10.1111/ajt.13848] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 6.2] [Reference Citation Analysis]
54 Wiebe C, Rush DN, Gibson IW, Pochinco D, Birk PE, Goldberg A, Blydt-Hansen T, Karpinski M, Shaw J, Ho J, Nickerson PW. Evidence for the alloimmune basis and prognostic significance of Borderline T cell-mediated rejection. Am J Transplant 2020;20:2499-508. [PMID: 32185878 DOI: 10.1111/ajt.15860] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 6.5] [Reference Citation Analysis]
55 DiLoreto R, Khush K, De Vlaminck I. Precision monitoring of immunotherapies in solid organ and hematopoietic stem cell transplantation. Adv Drug Deliv Rev 2017;114:272-84. [PMID: 28625828 DOI: 10.1016/j.addr.2017.06.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
56 Süsal C, Roelen DL, Fischer G, Campos EF, Gerbase-DeLima M, Hönger G, Schaub S, Lachmann N, Martorell J, Claas F. Algorithms for the determination of unacceptable HLA antigen mismatches in kidney transplant recipients. Tissue Antigens. 2013;82:83-92. [PMID: 23718733 DOI: 10.1111/tan.12137] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
57 Clatworthy MR. B-cell regulation and its application to transplantation. Transpl Int 2014;27:117-28. [PMID: 23909582 DOI: 10.1111/tri.12160] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
58 Huang E, Sethi S, Peng A, Najjar R, Mirocha J, Haas M, Vo A, Jordan SC. Early clinical experience using donor-derived cell-free DNA to detect rejection in kidney transplant recipients. Am J Transplant. 2019;19:1663-1670. [PMID: 30725531 DOI: 10.1111/ajt.15289] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 18.0] [Reference Citation Analysis]
59 Pascual J, Zuckermann A, Djamali A, Hertig A, Naesens M. Rabbit antithymocyte globulin and donor-specific antibodies in kidney transplantation — A review. Transplantation Reviews 2016;30:85-91. [DOI: 10.1016/j.trre.2015.12.002] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
60 Mohan S, Palanisamy A, Tsapepas D, Tanriover B, Crew RJ, Dube G, Ratner LE, Cohen DJ, Radhakrishnan J. Donor-specific antibodies adversely affect kidney allograft outcomes. J Am Soc Nephrol. 2012;23:2061-2071. [PMID: 23160511 DOI: 10.1681/asn.2012070664] [Cited by in Crossref: 181] [Cited by in F6Publishing: 58] [Article Influence: 18.1] [Reference Citation Analysis]
61 Süsal C, Opelz G. Current role of human leukocyte antigen matching in kidney transplantation. Curr Opin Organ Transplant 2013;18:438-44. [PMID: 23838649 DOI: 10.1097/MOT.0b013e3283636ddf] [Cited by in Crossref: 88] [Cited by in F6Publishing: 30] [Article Influence: 9.8] [Reference Citation Analysis]
62 Platt JL, Kaufman CL, Garcia de Mattos Barbosa M, Cascalho M. Accommodation and related conditions in vascularized composite allografts. Curr Opin Organ Transplant 2017;22:470-6. [PMID: 28682798 DOI: 10.1097/MOT.0000000000000446] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 2.8] [Reference Citation Analysis]
63 Bräutigam M, Volken T, Plattner A, Passweg JR, Halter JP, Drexler B, Heim D, Schaub S, Buser AS, Infanti L, Holbro A. Frequency, reactivity and evolution of human leukocyte antigen and human platelet antigen antibodies in the setting of hematopoietic cell transplantation. Transfus Apher Sci 2021;:103301. [PMID: 34774441 DOI: 10.1016/j.transci.2021.103301] [Reference Citation Analysis]
64 Geneugelijk K, Spierings E. Matching donor and recipient based on predicted indirectly recognizable human leucocyte antigen epitopes. Int J Immunogenet 2018;45:41-53. [PMID: 29464898 DOI: 10.1111/iji.12359] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
65 Osickova K, Hruba P, Kabrtova K, Klema J, Maluskova J, Slavcev A, Slatinska J, Marada T, Böhmig GA, Viklicky O. Predictive Potential of Flow Cytometry Crossmatching in Deceased Donor Kidney Transplant Recipients Subjected to Peritransplant Desensitization. Front Med (Lausanne) 2021;8:780636. [PMID: 34970564 DOI: 10.3389/fmed.2021.780636] [Reference Citation Analysis]
66 Cioni M, Nocera A, Innocente A, Tagliamacco A, Trivelli A, Basso S, Quartuccio G, Fontana I, Magnasco A, Drago F, Gurrado A, Guido I, Compagno F, Garibotto G, Klersy C, Verrina E, Ghiggeri GM, Cardillo M, Comoli P, Ginevri F. De Novo Donor-Specific HLA Antibodies Developing Early or Late after Transplant Are Associated with the Same Risk of Graft Damage and Loss in Nonsensitized Kidney Recipients. J Immunol Res 2017;2017:1747030. [PMID: 28367453 DOI: 10.1155/2017/1747030] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
67 Jung HY, Cho SY, Choi JY, Cho JH, Park SH, Kim YL, Kim HK, Huh S, Won DI, Kim CD. Comparison of Transplant Outcomes for Low-level and Standard-level Tacrolimus at Different Time Points after Kidney Transplantation. J Korean Med Sci 2019;34:e103. [PMID: 30940998 DOI: 10.3346/jkms.2019.34.e103] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
68 Visentin J, Bachelet T, Borg C, Franchini N, Nong T, Lee J, Couzi L, Merville P, Guidicelli G, Taupin J. Reassessment of T Lymphocytes Crossmatches Results Prediction With Luminex Class I Single Antigen Flow Beads Assay. Transplantation 2017;101:624-30. [DOI: 10.1097/tp.0000000000001239] [Cited by in Crossref: 19] [Cited by in F6Publishing: 2] [Article Influence: 3.8] [Reference Citation Analysis]
69 Salvadori M, Bertoni E. Impact of donor-specific antibodies on the outcomes of kidney graft: Pathophysiology, clinical, therapy. World J Transplant 2014; 4(1): 1-17 [PMID: 24669363 DOI: 10.5500/wjt.v4.i1.1] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
70 Djamali A, Kaufman DB, Ellis TM, Zhong W, Matas A, Samaniego M. Diagnosis and management of antibody-mediated rejection: current status and novel approaches. Am J Transplant 2014;14:255-71. [PMID: 24401076 DOI: 10.1111/ajt.12589] [Cited by in Crossref: 241] [Cited by in F6Publishing: 201] [Article Influence: 30.1] [Reference Citation Analysis]
71 Nishio-lucar A, Balogun RA, Sanoff S. Therapeutic apheresis in kidney transplantation: A review of renal transplant immunobiology and current interventions with apheresis medicine: Apheresis and Kidney Transplant. J Clin Apheresis 2013;28:56-63. [DOI: 10.1002/jca.21268] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
72 Fasano RM, Sullivan HC, Bray RA, Gebel HM, Meyer EK, Winkler AM, Josephson CD, Stowell SR, Sandy Duncan A, Roback JD. Genotyping Applications for Transplantation and Transfusion Management: The Emory Experience. Arch Pathol Lab Med 2017;141:329-40. [PMID: 28234571 DOI: 10.5858/arpa.2016-0277-SA] [Cited by in Crossref: 18] [Cited by in F6Publishing: 2] [Article Influence: 3.6] [Reference Citation Analysis]
73 Hirt-Minkowski P, Amico P, Hönger G, Praehauser C, Steiger J, Koller MT, Gürke L, Mayr M, Schaub S. Delayed graft function is not associated with an increased incidence of renal allograft rejection. Clin Transplant. 2012;26:E624-E633. [PMID: 23106785 DOI: 10.1111/ctr.12041] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
74 Buttigieg J, Ali H, Sharma A, Halawa A. Positive Luminex and negative flow cytometry in kidney transplantation: a systematic review and meta-analysis. Nephrology Dialysis Transplantation 2019;34:1950-60. [DOI: 10.1093/ndt/gfy349] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
75 Wehmeier C, Amico P, Sidler D, Wirthmüller U, Hadaya K, Ferrari-Lacraz S, Golshayan D, Aubert V, Schnyder A, Sunic K, Schachtner T, Nilsson J, Schaub S; Swiss Transplant Cohort Study. Pre-transplant donor-specific HLA antibodies and risk for poor first-year renal transplant outcomes: results from the Swiss Transplant Cohort Study. Transpl Int 2021. [PMID: 34561920 DOI: 10.1111/tri.14119] [Reference Citation Analysis]
76 Orandi BJ, Chow EH, Hsu A, Gupta N, Van Arendonk KJ, Garonzik-Wang JM, Montgomery JR, Wickliffe C, Lonze BE, Bagnasco SM, Alachkar N, Kraus ES, Jackson AM, Montgomery RA, Segev DL. Quantifying renal allograft loss following early antibody-mediated rejection. Am J Transplant 2015;15:489-98. [PMID: 25611786 DOI: 10.1111/ajt.12982] [Cited by in Crossref: 62] [Cited by in F6Publishing: 57] [Article Influence: 8.9] [Reference Citation Analysis]
77 Persaud SP, Duffy B, Phelan DL, Mohanakumar T, Delos Santos R, Gaut JP, Liu C. Accelerated humoral renal allograft rejection due to HLA-C14 mediated allosensitization to HLA-Bw6. Human Immunology 2017;78:692-8. [DOI: 10.1016/j.humimm.2017.09.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
78 Good-Weber M, Roos M, Mueller TF, Rüsi B, Fehr T. Tailored immunosuppression after kidney transplantation - a single center real-life experience. BMC Nephrol 2020;21:501. [PMID: 33228545 DOI: 10.1186/s12882-020-02137-5] [Reference Citation Analysis]
79 Pankewycz O, Soliman K, Laftavi MR. The increasing clinical importance of alloantibodies in kidney transplantation. Immunological Investigations 2014;43:775-89. [DOI: 10.3109/08820139.2014.910016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
80 Frobel AK, Karlsson MO, Backman JT, Hoppu K, Qvist E, Seikku P, Jalanko H, Holmberg C, Keizer RJ, Fanta S, Jönsson S. A time-to-event model for acute rejections in paediatric renal transplant recipients treated with ciclosporin A. Br J Clin Pharmacol 2013;76:603-15. [PMID: 23521314 DOI: 10.1111/bcp.12121] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
81 Hönger G, Fornaro I, Granado C, Tiercy J, Hösli I, Schaub S. Frequency and Determinants of Pregnancy-Induced Child-Specific Sensitization: Pregnancy-Induced Sensitization. American Journal of Transplantation 2013;13:746-53. [DOI: 10.1111/ajt.12048] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 5.0] [Reference Citation Analysis]
82 Kim B, Kang M, Lee JK, Lee HS, Park Y. Perioperative blood usage and therapeutic plasma exchange in kidney transplantation during a 16-year period in South Korea. Blood Transfus 2021;19:102-12. [PMID: 32530400 DOI: 10.2450/2020.0050-20] [Reference Citation Analysis]
83 Orandi BJ, Garonzik-wang JM, Massie AB, Zachary AA, Montgomery JR, Van Arendonk KJ, Stegall MD, Jordan SC, Oberholzer J, Dunn TB, Ratner LE, Kapur S, Pelletier RP, Roberts JP, Melcher ML, Singh P, Sudan DL, Posner MP, El-amm JM, Shapiro R, Cooper M, Lipkowitz GS, Rees MA, Marsh CL, Sankari BR, Gerber DA, Nelson PW, Wellen J, Bozorgzadeh A, Gaber AO, Montgomery RA, Segev DL. Quantifying the Risk of Incompatible Kidney Transplantation: A Multicenter Study: Incompatible Kidney Transplant Outcomes. American Journal of Transplantation 2014;14:1573-80. [DOI: 10.1111/ajt.12786] [Cited by in Crossref: 121] [Cited by in F6Publishing: 103] [Article Influence: 15.1] [Reference Citation Analysis]
84 Gubensek J, Buturovic-Ponikvar J, Kandus A, Arnol M, Lindic J, Kovac D, Rigler AA, Romozi K, Ponikvar R. Treatment of Antibody-Mediated Rejection After Kidney Transplantation - 10 Years' Experience With Apheresis at a Single Center. Ther Apher Dial 2016;20:240-5. [PMID: 27312908 DOI: 10.1111/1744-9987.12430] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
85 Park KS, Shin JH, Jang HR, Lee JE, Huh WS, Kim YG, Oh HY, Kim DJ. Impact of donor kidney function and donor age on poor outcome of living-unrelated kidney transplantation (KT) in comparison with living-related KT. Clin Transplant 2014;28:953-60. [PMID: 24861232 DOI: 10.1111/ctr.12388] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
86 Wu P, Jin J, Everly MJ, Lin C, Terasaki PI, Chen J. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation. Clin Biochem 2013;46:1389-93. [PMID: 23726814 DOI: 10.1016/j.clinbiochem.2013.05.053] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
87 Nocera A, Tagliamacco A, Cioni M, Innocente A, Fontana I, Barbano G, Carrea A, Ramondetta M, Sementa A, Basso S, Quartuccio G, Klersy C, Bertocchi M, Verrina E, Garibotto G, Ghiggeri GM, Cardillo M, Comoli P, Ginevri F. Kidney Intragraft Homing of De Novo Donor-Specific HLA Antibodies Is an Essential Step of Antibody-Mediated Damage but Not Per Se Predictive of Graft Loss. Am J Transplant 2017;17:692-702. [DOI: 10.1111/ajt.14000] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
88 Abou-Jaoudé M, El Hage S, Akiki D, Araman R. Effect of donor-to-recipient HLA matching in low-immunological risk kidney transplant recipients without induction therapy on acute rejection, graft survival, infections, and surgical complications at 3 years: The road towards new recommendations. Transpl Immunol 2021;69:101490. [PMID: 34695578 DOI: 10.1016/j.trim.2021.101490] [Reference Citation Analysis]
89 Betjes MGH, Sablik KS, Otten HG, Roelen DL, Claas FH, de Weerd A. Pretransplant Donor-Specific Anti-HLA Antibodies and the Risk for Rejection-Related Graft Failure of Kidney Allografts. J Transplant 2020;2020:5694670. [PMID: 32099669 DOI: 10.1155/2020/5694670] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
90 Tan X, Feng H, Guo Z, Wang L, Fu C, Sun L, Li Y, Xia Q, Hou L, Liu C, Zhu L, Chen G. Rabbit antithymocyte globulin induces human lymphocyte activation, proliferation, and apoptosis in the absence of complement: an experimental study. Transpl Int 2021;34:930-41. [PMID: 33725365 DOI: 10.1111/tri.13864] [Reference Citation Analysis]
91 Leonard DA, Kurtz JM, Cetrulo CL Jr. Vascularized composite allotransplantation: towards tolerance and the importance of skin-specific immunobiology. Curr Opin Organ Transplant 2013;18:645-51. [PMID: 24126805 DOI: 10.1097/MOT.0000000000000022] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
92 Malheiro J, Tafulo S, Dias L, Martins S, Fonseca I, Beirão I, Castro-Henriques A, Cabrita A. Deleterious effect of anti-angiotensin II type 1 receptor antibodies detected pretransplant on kidney graft outcomes is both proper and synergistic with donor-specific anti-HLA antibodies. Nephrology (Carlton) 2019;24:347-56. [PMID: 29451342 DOI: 10.1111/nep.13239] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
93 Cascalho MI, Chen BJ, Kain M, Platt JL. The paradoxical functions of B cells and antibodies in transplantation. J Immunol 2013;190:875-9. [PMID: 23335803 DOI: 10.4049/jimmunol.1100120] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
94 Israeli M, Pollack MS, Shaut CA, Halpin A, DiPaola NR, Youngs D, Saidman SL; ASHI Proficiency Testing Program. Concordance and discordance in anti-HLA antibody testing. Transpl Immunol 2015;32:1-8. [PMID: 25460810 DOI: 10.1016/j.trim.2014.10.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
95 Jani V, Ingulli E, Mekeel K, Morris GP. Root cause analysis of limitations of virtual crossmatch for kidney allocation to highly-sensitized patients. Human Immunology 2017;78:72-9. [DOI: 10.1016/j.humimm.2016.11.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
96 Freire MP, Antonopoulos IM, Piovesan AC, Moura ML, de Paula FJ, Spadão F, Guimarães T, David-Neto E, Nahas WC, Pierrotti LC. Amikacin prophylaxis and risk factors for surgical site infection after kidney transplantation. Transplantation 2015;99:521-7. [PMID: 25254907 DOI: 10.1097/TP.0000000000000381] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
97 Ixtlapale-Carmona X, Arvizu A, De-Santiago A, González-Tableros N, López M, Castelán N, Marino LA, Uribe-Uribe NO, Contreras AG, Vilatobá M, Morales-Buenrostro LE, Alberú J. Graft immunologic events in deceased donor kidney transplant recipients with preformed HLA-donor specific antibodies. Transpl Immunol 2018;46:8-13. [PMID: 28974434 DOI: 10.1016/j.trim.2017.09.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
98 Speck NE, Schuurmans MM, Murer C, Benden C, Huber LC. Diagnostic value of plasma and bronchoalveolar lavage samples in acute lung allograft rejection: differential cytology. Respir Res 2016;17:74. [PMID: 27323950 DOI: 10.1186/s12931-016-0391-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
99 Cioni M, Comoli P, Tagliamacco A, Innocente A, Basso S, Fontana I, Magnasco A, Trivelli A, Nocco A, Macchiagodena M, Catenacci L, Klersy C, Verrina E, Garibotto G, Ghiggeri GM, Cardillo M, Ginevri F, Nocera A. Post-transplant de novo non donor-specific HLA antibodies are not associated with poor graft outcome in non-sensitized pediatric recipients of kidney transplantation. Transpl Immunol 2021;65:101375. [PMID: 33610675 DOI: 10.1016/j.trim.2021.101375] [Reference Citation Analysis]
100 Bostock IC, Alberú J, Arvizu A, Hernández-Mendez EA, De-Santiago A, González-Tableros N, López M, Castelán N, Contreras AG, Morales-Buenrostro LE, Gabilondo B, Vilatobá M. Probability of deceased donor kidney transplantation based on % PRA. Transpl Immunol 2013;28:154-8. [PMID: 23684945 DOI: 10.1016/j.trim.2013.05.002] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
101 Wang CJ, Tuffaha A, Zhang D, Diederich DA, Wetmore JB. A CD3+ count-based thymoglobulin induction regimen permits delayed introduction of calcineurin inhibitors in kidney transplantation. Clin Transplant 2012;26:900-9. [PMID: 22672562 DOI: 10.1111/j.1399-0012.2012.01656.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
102 Randhawa P. T-cell-mediated rejection of the kidney in the era of donor-specific antibodies: diagnostic challenges and clinical significance. Curr Opin Organ Transplant 2015;20:325-32. [PMID: 25944230 DOI: 10.1097/MOT.0000000000000189] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
103 Lin J, Wang R, Xu Y, Chen J. Impact of renal allograft nephrectomy on graft and patient survival following retransplantation: a systematic review and meta-analysis. Nephrology Dialysis Transplantation 2018;33:700-8. [DOI: 10.1093/ndt/gfx360] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
104 Gombos P, Opelz G, Scherer S, Morath C, Zeier M, Schemmer P, Süsal C. Influence of Test Technique on Sensitization Status of Patients on the Kidney Transplant Waiting List: Single Antigen Assay and Sensitization Status. American Journal of Transplantation 2013;13:2075-82. [DOI: 10.1111/ajt.12332] [Cited by in Crossref: 69] [Cited by in F6Publishing: 62] [Article Influence: 7.7] [Reference Citation Analysis]
105 Wang Z, Zhang H, Yang H, Zheng M, Guo M, Chen H, Sun L, Han Z, Tao J, Ju X, Tan R, Wei JF, Gu M. An intronic polymorphism of NFATC1 gene shows a risk association with biopsy-proven acute rejection in renal transplant recipients. Ann Transl Med 2020;8:211. [PMID: 32309358 DOI: 10.21037/atm.2020.01.61] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
106 Gerlach UA, Lachmann N, Sawitzki B, Arsenic R, Neuhaus P, Schoenemann C, Pascher A. Clinical relevance of the de novo production of anti-HLA antibodies following intestinal and multivisceral transplantation. Transpl Int. 2014;27:280-289. [PMID: 24279605 DOI: 10.1111/tri.12250] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 5.4] [Reference Citation Analysis]
107 Shang W, Dong L, Feng G, Wang Y, Pang X, Li J, Liu L, Zhang W. Panel-reactive antibody levels and renal transplantation rates in sensitized patients after desensitization and human leucocyte antigen amino acid residue matching. J Int Med Res 2013;41:1333-41. [PMID: 23780877 DOI: 10.1177/0300060513485896] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
108 Phillpott M, Daga S, Higgins R, Lowe D, Krishnan N, Zehnder D, Briggs D, Khovanova N. Dynamic Behaviour of Donor Specific Antibodies in the Early Period Following HLA Incompatible Kidney Transplantation. Transpl Int 2022;35:10128. [PMID: 35516975 DOI: 10.3389/ti.2022.10128] [Reference Citation Analysis]
109 Ramon DS, Huang Y, Zhao L, Rendulic T, Park JM, Sung RS, Samaniego M. Use of complement binding assays to assess the efficacy of antibody mediated rejection therapy and prediction of graft survival in kidney transplantation. Hum Immunol 2017;78:57-63. [PMID: 27894836 DOI: 10.1016/j.humimm.2016.11.009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
110 Ejaz NS, Shields AR, Alloway RR, Sadaka B, Girnita AL, Mogilishetty G, Cardi M, Woodle ES. Randomized controlled pilot study of B cell-targeted induction therapy in HLA sensitized kidney transplant recipients. Am J Transplant 2013;13:3142-54. [PMID: 24266968 DOI: 10.1111/ajt.12493] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 3.2] [Reference Citation Analysis]
111 Jucaud V, Ravindranath MH, Terasaki PI. Conformational Variants of the Individual HLA-I Antigens on Luminex Single Antigen Beads Used in Monitoring HLA Antibodies: Problems and Solutions. Transplantation 2017;101:764-77. [PMID: 27495776 DOI: 10.1097/TP.0000000000001420] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 3.2] [Reference Citation Analysis]
112 Wehmeier C, Hönger G, Cun H, Amico P, Hirt-Minkowski P, Georgalis A, Hopfer H, Dickenmann M, Steiger J, Schaub S. Donor Specificity but Not Broadness of Sensitization Is Associated With Antibody-Mediated Rejection and Graft Loss in Renal Allograft Recipients. Am J Transplant 2017;17:2092-102. [PMID: 28245084 DOI: 10.1111/ajt.14247] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 8.0] [Reference Citation Analysis]
113 Seok H, Huh K, Cho SY, Kang CI, Chung DR, Huh WS, Park JB, Peck KR. Invasive Fungal Diseases in Kidney Transplant Recipients: Risk Factors for Mortality. J Clin Med 2020;9:E1824. [PMID: 32545280 DOI: 10.3390/jcm9061824] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
114 Teoh CW, Korus M, Lorenzo A, Langlois V. Preparing the Child with End-Stage Renal Disease for a Renal Transplant: the Pre-transplant Assessment. Curr Pediatr Rep 2020;8:134-46. [DOI: 10.1007/s40124-020-00225-6] [Reference Citation Analysis]
115 Tagliamacco A, Biticchi R, Garibotto G, Ginevri F, Nocera A. Gene expression in highly sensitized dialysis patients waiting for a kidney transplant: A real-time PCR analysis. Transpl Immunol 2015;33:166-7. [PMID: 26475986 DOI: 10.1016/j.trim.2015.10.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
116 Senev A, Lerut E, Van Sandt V, Coemans M, Callemeyn J, Sprangers B, Kuypers D, Emonds M, Naesens M. Specificity, strength, and evolution of pretransplant donor‐specific HLA antibodies determine outcome after kidney transplantation. Am J Transplant 2019;19:3100-13. [DOI: 10.1111/ajt.15414] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 8.3] [Reference Citation Analysis]
117 Geneugelijk K, Thus KA, Spierings E. Predicting alloreactivity in transplantation. J Immunol Res 2014;2014:159479. [PMID: 24868561 DOI: 10.1155/2014/159479] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 4.1] [Reference Citation Analysis]
118 Malheiro J, Tafulo S, Dias L, Martins LS, Fonseca I, Beirão I, Castro-Henriques A, Cabrita A. Analysis of preformed donor-specific anti-HLA antibodies characteristics for prediction of antibody-mediated rejection in kidney transplantation. Transpl Immunol 2015;32:66-71. [PMID: 25661873 DOI: 10.1016/j.trim.2015.01.002] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 5.4] [Reference Citation Analysis]
119 Liu W, Zhao J, Kang ZY, Xiao YL, Yang L, Liu C, Li DH. De novo donor-specific HLA antibodies reduce graft survival rates and increase the risk of kidney transplant rejection: A single-center retrospective study. Transpl Immunol 2021;68:101430. [PMID: 34147608 DOI: 10.1016/j.trim.2021.101430] [Reference Citation Analysis]
120 Zhang H, Fu Q, Zheng Y, Li J, Wang S, Deng R, Huang G, Deng W, Huang H, Liu L, Wang C. Effect of Early Immunosuppression Therapy on De Novo Anti-Human-Leukocyte-Antigen Antibody After Kidney Transplantation. Transplant Proc 2018;50:2382-7. [PMID: 30316362 DOI: 10.1016/j.transproceed.2018.03.043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
121 Everly MJ, Rebellato LM, Haisch CE, Briley KP, Bolin P, Kendrick WT, Kendrick SA, Morgan C, Maldonado AQ, Harland RC, Terasaki PI. Impact of IgM and IgG3 anti-HLA alloantibodies in primary renal allograft recipients. Transplantation 2014;97:494-501. [PMID: 24487396 DOI: 10.1097/01.TP.0000441362.11232.48] [Cited by in Crossref: 49] [Cited by in F6Publishing: 18] [Article Influence: 6.1] [Reference Citation Analysis]
122 Visentin J, Marroc M, Guidicelli G, Bachelet T, Nong T, Moreau JF, Lee JH, Merville P, Couzi L, Taupin JL. Clinical impact of preformed donor-specific denatured class I HLA antibodies after kidney transplantation. Clin Transplant 2015;29:393-402. [PMID: 25683727 DOI: 10.1111/ctr.12529] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
123 Tagliamacco A, Cioni M, Comoli P, Ramondetta M, Brambilla C, Trivelli A, Magnasco A, Biticchi R, Fontana I, Dulbecco P, Palombo D, Klersy C, Ghiggeri GM, Ginevri F, Cardillo M, Nocera A. DQ molecules are the principal stimulators of de novo donor-specific antibodies in nonsensitized pediatric recipients receiving a first kidney transplant. Transpl Int 2014;27:667-73. [DOI: 10.1111/tri.12316] [Cited by in Crossref: 45] [Cited by in F6Publishing: 33] [Article Influence: 5.6] [Reference Citation Analysis]
124 Dieplinger G, Everly MJ, Rebellato LM, Haisch CE, Briley KP, Bolin P, Kendrick WT, Kendrick SA, Morgan C, Harland RC, Terasaki PI. Changes in Successive Measures of De Novo Donor-Specific Anti–Human Leukocyte Antigen Antibodies Intensity and The Development of Allograft Dysfunction. Transplantation 2014;98:1097-104. [DOI: 10.1097/tp.0000000000000190] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
125 Guedes AM, Malheiro J, Fonseca I, Martins LS, Pedroso S, Almeida M, Dias L, Castro Henriques A, Cabrita A. Over ten-year kidney graft survival determinants. Int J Nephrol 2012;2012:302974. [PMID: 23213526 DOI: 10.1155/2012/302974] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
126 Sis B, Bagnasco SM, Cornell LD, Randhawa P, Haas M, Lategan B, Magil AB, Herzenberg AM, Gibson IW, Kuperman M, Sasaki K, Kraus ES; Banff Working Group. Isolated endarteritis and kidney transplant survival: a multicenter collaborative study. J Am Soc Nephrol 2015;26:1216-27. [PMID: 25381427 DOI: 10.1681/ASN.2014020157] [Cited by in Crossref: 25] [Cited by in F6Publishing: 10] [Article Influence: 3.1] [Reference Citation Analysis]
127 Kwon H, Kim YH, Choi JY, Shin S, Jung JH, Park S, Han DJ. Impact of pretransplant donor-specific antibodies on kidney allograft recipients with negative flow cytometry cross-matches. Clin Transplant 2018;32:e13266. [DOI: 10.1111/ctr.13266] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
128 Chacko MP, Mathan A, Daniel D, Basu G, Varughese S. Significance of pre-transplant anti-HLA antibodies detected on an ELISA mixed antigen tray platform. Indian J Nephrol 2013;23:351-3. [PMID: 24049271 DOI: 10.4103/0971-4065.116303] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
129 Gebel HM, Liwski RS, Bray RA. Technical aspects of HLA antibody testing. Curr Opin Organ Transplant. 2013;18:455-462. [PMID: 23838651 DOI: 10.1097/mot.0b013e32836361f1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
130 Gebel HM, Bray RA. HLA Antibody Detection With Solid Phase Assays: Great Expectations or Expectations Too Great?: Solid Phase Antibody Detection. American Journal of Transplantation 2014;14:1964-75. [DOI: 10.1111/ajt.12807] [Cited by in Crossref: 93] [Cited by in F6Publishing: 88] [Article Influence: 11.6] [Reference Citation Analysis]
131 Carmellini M, Garcia V, Wang Z, Vergara M, Russ G. Efficacy of everolimus with reduced-exposure cyclosporine in de novo kidney transplant patients at increased risk for efficacy events: analysis of a randomized trial. J Nephrol 2015;28:633-9. [PMID: 25708913 DOI: 10.1007/s40620-015-0180-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
132 da Silva CK, Meinerz G, Bruno RM, Abud J, Montagner J, Dorsdt DMB, Coutinho AK, Neumann J, Garcia VD, Keitel E. Late impact of preformed anti-HLA antibodies on kidney graft outcome. Transpl Immunol 2019;55:101212. [PMID: 31254612 DOI: 10.1016/j.trim.2019.06.004] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
133 Laging M, Kal-van Gestel JA, Haasnoot GW, Claas FH, van de Wetering J, Ijzermans JN, Weimar W, Roodnat JI. Transplantation results of completely HLA-mismatched living and completely HLA-matched deceased-donor kidneys are comparable. Transplantation 2014;97:330-6. [PMID: 24202143 DOI: 10.1097/01.TP.0000435703.61642.43] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
134 Matz M, Lehnert M, Lorkowski C, Fabritius K, Unterwalder N, Doueiri S, Weber UA, Mashreghi MF, Neumayer HH, Budde K. Effects of sotrastaurin, mycophenolic acid and everolimus on human B-lymphocyte function and activation. Transpl Int. 2012;25:1106-1116. [PMID: 22816666 DOI: 10.1111/j.1432-2277.2012.01537.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
135 Huber L, Lachmann N, Niemann M, Naik M, Liefeldt L, Glander P, Schmidt D, Halleck F, Waiser J, Brakemeier S, Neumayer HH, Schönemann C, Budde K. Pretransplant virtual PRA and long-term outcomes of kidney transplant recipients. Transpl Int 2015;28:710-9. [DOI: 10.1111/tri.12533] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
136 Ginevri F, Nocera A, Comoli P, Innocente A, Cioni M, Parodi A, Fontana I, Magnasco A, Nocco A, Tagliamacco A, Sementa A, Ceriolo P, Ghio L, Zecca M, Cardillo M, Garibotto G, Ghiggeri GM, Poli F. Posttransplant De Novo Donor-Specific HLA Antibodies Identify Pediatric Kidney Recipients at Risk for Late Antibody-Mediated Rejection: Impact of De Novo DSA in Pediatric Kidney Recipients . American Journal of Transplantation 2012;12:3355-62. [DOI: 10.1111/j.1600-6143.2012.04251.x] [Cited by in Crossref: 113] [Cited by in F6Publishing: 98] [Article Influence: 11.3] [Reference Citation Analysis]
137 Fung A, Zhao H, Yang B, Lian Q, Ma D. Ischaemic and inflammatory injury in renal graft from brain death donation: an update review. J Anesth 2016;30:307-16. [DOI: 10.1007/s00540-015-2120-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
138 Callemeyn J, Lamarthée B, Koenig A, Koshy P, Thaunat O, Naesens M. Allorecognition and the spectrum of kidney transplant rejection. Kidney Int 2021:S0085-2538(21)01143-1. [PMID: 34915041 DOI: 10.1016/j.kint.2021.11.029] [Reference Citation Analysis]